Background: Klinefelter syndrome (KS) is one of the major causes of nonobstructive azoospermia (NOA). Microdissection testicular sperm extraction (micro-TESE) is often performed to retrieve sperm. Infertility specialists have to care for KS patients on a lifelong basis.
| INTRODUC TI ON
In 1942, Klinefelter and Albright reported that nine men had a "Syndrome characterized by gynecomastia, aspermatogenesis without Leydigism and increased excretion of follicle-stimulating hormone". 1 Karyotype analysis elucidated that this syndrome was caused by an extra X chromosome (XXY). The classic form (nonmosaic type) of Klinefelter syndrome (KS) is observed in one per 660 births, with up to 3%-4% occurring in infertile men and 10%-12% occurring in nonobstructive azoospermia (NOA). A study on the KS prevalence in Japan found a lower prevalence at 60 per 100 000, 2 indicating the presence of racial differences. KS is the most common sex chromosome abnormality associated with male infertility, 3, 4 and men with KS have been shown to be potentially fertile by using a testicular sperm and intracytoplasmic sperm injection (ICSI) protocol. 6 Approximately 85% of KS cases are due to a single aberrant X chromosome (47, XXY) , whereas the remaining 15% display multiple aneuploidies (48,XXXY; 48,XXYY; 49,XXXXY), causing the development of more severe phenotypes, which are usually diagnosed during prenatal and infantile periods as abnormalities of the external
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SHIRAISHI And MATSUYAMA genitalia. 7 A structurally abnormal X chromosome (eg, 47,iXq,Y) or mosaicisms (eg, 47,XXY/46,XY) are also included in KS. The origin of the aberrant X chromosome in KS, of either paternal or maternal origin, and how the presence of a supernumerary X chromosome causes the phenotype and morbidity in KS are not fully understood.
The multiple aneuploidies causing the abnormalities of external genitalia and children with KS with severe intellectual and behavioral problems are relatively rare compared with other cases of male infertility, usually NOA. These are symptoms often present among men with KS, and in most of the cases, lead to its diagnosis during the workup for infertility. Less than 10% of these patients are diagnosed before puberty. 3 On the other hand, we should not forget that KS is also responsible for general comorbidities related to metabolic and psychological disorders and risks of specific malignancies, which, in part, are caused by low testosterone in KS patients. As microdissection testicular sperm extraction (micro-TESE) has been shown to be an ideal sperm retrieval method 8 used by many urologists and, in Japan, gynecologists, the chances of low-testosteronerelated symptoms and comorbidities are increasing. The testicular size is significantly smaller and serum testosterone levels are lower in KS patients compared to those in other NOA cases; thus, a postmicro-TESE decline in testosterone is enhanced in KS patients. 9 Unfortunately, we often see many KS patients who claim to have impaired sexual function, general fatigue, and comorbidities after micro-TESE, and they are not properly followed up after micro-TESE irrespective of the results of sperm retrieval. Diagnosing KS should be the beginning of a strict follow-up of general health; however, reproductive medicine has caused new and severely low levels of testosterone in men with KS in the era of assisted reproductive technologies (ART).
Data related to infertility treatment are apt to be focused on the sperm retrieval of KS. The purposes of this review are to understand the background pathophysiology of KS patients, including how they grew up, which symptoms occurred before they were treated for infertility, what information is available after their infertility treatment, and finally how they should be managed for lifelong basis. 9 and a recent meta-analysis has shown that men with KS and men with NOA had the strongest decreases in total testosterone levels at 6 months after TESE. 21 The largest disaster regarding this issue is that a majority of men with KS are not properly followed up after micro-TESE, which will be addressed in another section in this review.
| K S AND INFERTILIT Y TRE ATMENT

| PRENATAL , INFANTILE , AND PED IATRI C PERI ODS
The opportunity for physicians to diagnose and manage KS may occur even during the prenatal period, as the diagnosis is sometimes established by prenatal genetic information. The recent development of noninvasive prenatal screening is anticipated to increase the number of couples seeking counseling; however, a discussion on whether to abort has never occurred in KS cases.
Studies in KS infants have found that the postnataltemporary surge in gonadotropins ("mini-puberty") may be accompanied by low testosterone levels 22, 23 or normal testosterone levels. 24, 25 Simultaneously, FSH levels increase at 2-3 months after birth, followed by a subsequent rapid decline. 25 This early exposure of androgens is severely disturbed with an increase in the number of X chromosomes. Genital anomalies (micropenis, undescended testis, bifid scrotum, and hypospadia) might present at birth, but whether they are due to the effects of supernumerary X chromosome(s) or androgen deficiency during the fetal period remains undetermined. Basically, testosterone-related symptoms do not occur during infancy or early pediatric periods. Signs and symptoms appearing during this period, such as longer legs, disturbance of speech and cognition,adaptation problems, attention deficits, and social skill impairments, 26, 27 have been attributed to the genetic abnormality rather than to hypogonadism. As a result, men with KS are prone to learning difficulties, and their academic and professional status achievements are reported to be inferior to those without KS 28 ; however, this finding has not been fully investigated, and men with KS who visit our infertility clinic, of course they are only limited cases of KS, are always highly educated and talented. The management of children with KS warrants the collaboration of a multidisciplinary team consisting of pediatricians as well as behavioral specialists to ameliorate the developmental defects in early life. 29 In addition, an echocardiographic study should be performed to reveal congenital cardiovascular abnormalities. 30 Although multidisciplinary treatment for each child with KS should be administered and testosterone may not play a major role in the treatment of KS during this period, there are some anticipated benefits of testosterone replacement therapy (TRT) on the improvement of the energy level, attention span, mood, and cardiac health of young KS patients. 31, 32 Recently, two reports have indicated that early TRT may be beneficial for developmental and behavioral issues in boys with KS without serious adverse effects. 33, 34 However, there is concern that TRT might cause obstructive sleep apnea and venous thromboembolism. 35, 36 In addition, there is evidence that TRT in boys with KS is not as effective as that observed in males with a normal karyotype, at least regarding body proportions and bone mineral density (BMD). 37, 38 Studies that apply population-based genetic screening should be performed to investigate a proper evaluation of the costs and benefits of such an approach in KS patients. 39 Randomized controlled trials are also needed to evaluate the efficacy of TRT on different aspects of the symptoms, to determine optimal dose regimens and, most importantly, to prevent the impairment of spermatogenesis or to stimulate future spermatogenesis in boys with KS. 40 In this situation, psychological aspects regarding their future reproductive function should be taken into consideration to avoid negative impacts on reproductive health, and follow-up should be performed by a specialized team consisting of pediatricians, adult endocrinologists/andrologists, and psychologists during the transition from pediatric and adolescent periods to adulthood.
| ADOLE SCENT PERI OD
Although the onset of puberty in KS patients occurs at the same time as that in normal boys, hypogonadism remains silent until pubertal onset because testosterone levels are usually sufficient for satisfactory development of the body and genitalia. 41, 42 Additionally, the severity of low-testosterone-related symptoms is mild in KS patients during the adolescent period, unlike in male hypogonadotropic hypogonadism. Furthermore, the negative feedback elevation of LH activates aromatase, resulting in an increase in estradiol, which may contribute to the development of gynecomastia. 43 At puberty, only a few patients notice overt hypogonadism signs, such as poor muscle development, a short penis, and a lack of or sparse pubic, axillary, and facial hair. Low-to-normal testosterone levels contribute to the development of tall stature and disturb the ratio between the upper and lower skeletal segments. 44 On the other hand, Bojesen et al reported that 65%-85% of KS patients present overt hypogonadism after the age of 25, 45 and this number might differ among countries and according to the circumstances surrounding KS patients.
Along with LH, FSH is increased via the negative feedback mechanism of testosterone, estradiol, and inhibin B, whichultimately cause the hypergonadotropic levels observed in adult KS patients. 46 Additionally, we suspect that some disturbances in testicular development occur during this period. The testes of KS adolescents can develop to a volume of 6 mL due to the proliferation and maturation of Sertoli and Leydig cells, 47 which is considered to be normal initial testicular development. Rising intratesticular testosterone levels are subsequently followed by an accelerating decline in germ cells, 52 This phenomenon causes the presence of ejaculate sperm during the adolescent period in some KS patients, which leads to the hypothesis that SRR by TESE might be superior during the adolescent period rather than in the adult period to preserve future fertility potential.
| IS TE S E DURING ADOLE SCEN CE EFFEC TIVE IN K S PATIENTS?
Limited data suggest that sperm production in men with KS, as determined by the results of TESE, is rapidly impaired after a certain age (approximately 35 years of age), and it might be better to retrieve sperm as soon as the diagnosis is made. This suggestion was generated from data reported by Okada et al. 14 In their study, the SRR in 25 patients >35 years of age was only 23%. On the other hand, data from Cornell University showed that the SRR in men with KS was 71% in the 22-to 30-year age-group, 86% in the 31-to 35-year agegroup, and 50% in the 36-to 50-year age-group. In our experience, the SRR in 84 men with KS was 61% (11/18) The micro-TESE procedure performed in adolescent boys with KS was first performed by a Cornell group and reported by Mehta et al in 2013. Ten KS patients aged 14-22 years underwent micro-TESE, and mature sperm were found in seven patients (SRR: 70%).
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A subsequent publication from the same institution showed a 65% retrieval rate in 127 KS adult men, which was the same rate of success for adolescents and adults. 61 Plotten et al 62 Most importantly, we must consider how patients and their families feel about fertility preservation, especially in cases in which micro-TESE needs to be performed. A psychosocial investigation clearly demonstrates a high incidence of negative feelings toward infertility and its effect on overall life satisfaction and well-being. 64 Two other studies have shown that reproductive function is not an issue of awareness in adolescent boys with KS, whereas their parents and physicians appreciate fertility preservation at a young age.
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The influence of a TESE procedure on the psychological health of adolescents with KS has not been investigated, and further studies are warranted.
| P OS TINFERTILIT Y MANAG EMENT: D IAG NOS IS OF K S IS A PROX Y OF G ENER AL H E A LTH
A 26-year-old man with KS was referred to our clinic and complained of decreased libido and general fatigue. His testicular size was 0.5 mL bilaterally, and his total testosterone concentration was 15 ng/dL. He underwent micro-TESE at an IVF clinic 6 months prior to visit at our clinic, and his preoperative total testosterone level was 276 ng/dL. Unfortunately, no sperm were found in his testes, and his management was stopped at the clinic. At our hospital, he started TRT every 3 weeks, and his symptoms were dramatically improved.
This type of case is not rare but rather very common in our urology department. What are the problems in this case?
In addition to reproductive medicine, many urologists in Japan are engaged in general urology as well as nephrology, hemodialysis, and renal transplant, which enables a quick start to the management of comorbidities, such as hypertension, diabetes, dyslipidemia, and hyperuricemia, in most men with KS after infertility treatment (A) (B) Furthermore, we must make every effort to improve our ability to diagnose KS. The high frequency of mild KS phenotypes explains, at least in part, why a majority of the patients remain undiagnosed. 94 Bojesen and Gravholt (2011) 68 Ferlin et al (2015) those described in data from the United States and Europe (approximately 24-30). Investigations regarding the patterns of comorbidity and the TRT treatment regimen for KS patients from Japan and Asian countries are warranted.
Based on data from epidemiological studies, KS is associated with increased morbidity and mortality althoughall the information collected regarding KS is derived from diagnosed cases comprising only approximately 25% of the expected affected number of patients. 3, 66 In other words, the diagnosis of KS at the time of infertility treatment is a special opportunity to evaluate their general health, and patients and medical providers should begin follow-up and the management of comorbidities. Multidisciplinary management is needed for lifelong follow-up (Figure 3 ).
Comorbidities associated with KS, such as metabolic syndrome, diabetes, osteoporosis, and cardiovascular diseases, often appear in adulthood, with many of the patients being of reproductive age; these comorbidities increase with age, 67 which is ultimately related to a significant increase in mortality risk. Actually, men with KS require more frequent hospitalization, and the life span of KS patients appears to be shorter by approximately 2.1 years compared to that of the general population. 68 The main comorbidity associated with increased mortality risk is the increased prevalence of type 2 diabetes and thrombosis/embolism disorders, both of which are risk factors of cardiovascular events. 69 Other conditions increasing the morbidity of men with KS are osteoporosis and bone fractures as well as the higher prevalence of specific types of cancer and immunological diseases ( Table 1 ). The reason for this impaired mortality is not well understood, and further investigations are needed to clarify whether it is due to the syndrome per se or is mainly a consequence of low testosterone levels. A number of reports show that low testosterone is a biomarker for increased mortality in normal healthy men. 70 In addition to the comorbidities mentioned above, the loss of muscle and a depressed mood due to low testosterone are not directly related to mortality but are associated with a markedly decreased quality of life. 71 Of note, from observational studies, some positive effects of TRT in KS have been reported, including decreased fatigue, less irritability, and improved libido, muscle strength, and sleep. 72, 73 The general consensus indicates that most men with KS should be offered TRT around the time of puberty with a target testosterone level in the high normal range. 45 However, no randomized placebocontrolled trials have been performed to date to verify this recommendation, and data on future spermatogenesis remain unknown.
As a result, the timing of the initiation and the dose of TRT in KS patients remain topics for further investigation. Specifically, a study on treatment during the pediatric period showed promising results for improving behavior and neurodevelopment, 33 and this treatment could have an overall positive effect on social integration during the pediatric and adolescent periods and, presumably, also in adult life.
| KS and cancer
Breast cancer andgerm cell tumors, especially extragonadal tumors, occur more frequently in KS patients than in the general population (Table 1) . Several meta-analyses concerning the prevalence of male breast cancer have shown the incidence of breast cancer in KS to be increased 4-to 30-fold compared with that in normal men, 74, 75 which supports that KS is the strongest independent risk factor for breast cancer in males. 76 The mean age of breast cancer onset in KS patients is 58 years, 77 which is earlier than that of normal healthy men (67 years of age). 78 The early diagnosis of breast cancer requires monthly breast self-examination and a periodic physical examination by a specialized physician. 75 A markedly increased prevalence of germ cell tumors in KS patients has been confirmed in pathologybased studies, 79 and nonseminomatous tumors are the major pathological type. Additionally, the diagnosis occurs at a younger age in KS patients than in normal healthy men. A recent Italian consensus 80 suggests a biannual chest X-ray to address the risk of extragonadal germ cell tumors.
On the other hand, the prevalence of prostate cancer and the associated mortality have been reported to be lower in KS patients than in normal healthy men. 79, 81 The reason for these lower rates may be because the presence of hypogonadism does not stimulate the growth of prostate cancer cells, whereas recent studies cast doubt on the correlation between intraprostatic testosterone levels and the carcinogenesis and progression of prostate cancer. 82 Interestingly, the level of prostate-specific antigen, a marker of prostate cancer, stays below the normal range regardless of the presence of TRT. 
| KS and diabetes
In the general population, a clear relationship between the serum testosterone concentration and insulin sensitivity has been reported. 84, 85 Low testosterone levels are associated with increased insulin resistance, 86 and the onset of insulin resistance may be influenced by testosterone levels. 87, 88 Serum testosterone levels are independently associated with insulin resistance, suggesting that low testosterone might be responsible for diabetes (in this review, type 2 diabetes), 89 and a 5-fold increase in metabolic syndrome 38 96 In addition, Campbell et al found that the risks of pulmonary embolism and deep venous thrombosis were 5-20 times higher in KS patients than in normal healthy men. 97 The updated AUA guideline for the evaluation and management of testosterone deficiency indicates that whether TRT increases or decreases the risk of cardiovascular events cannot be definitively stated. This guideline also indicates that there is no definitive evidence linking TRT to a higher incidence of venous thromboembolic events. 98 Obviously, this guideline is for general hypogonadal men, and data on men with KS are needed for future investigations.
| KS and bone disease
Klinefelter syndrome patients also face an increased prevalence of bone disorders, particularly reduced BMD. A study found that 42.5% of KS patients had a combination of osteoporosis and osteopenia, which was 8-fold higher than the incidence in men with a normal karyotype. 99 Reduced BMD is caused by increased bone turnover and is accompanied by an increased risk of bone fractures, especially in the femoral area. Unlike fractures that occur in aging males, men with KS are more active, and the influence of fractures on their body and socioeconomic aspects are more serious. Furthermore, decreased BMD and fractures affecting morbidity and mortality 68, 95 have long been associated with KS. The mechanism of decreased BMD changes upon normal aging because the hypogonadism that occurs during the critical pubertal stages of bone development accompanying low physical exercise capacity and muscle strength is present in KS patients. TRT has been shown to improve BMD, 100 but vitamin D repletion has been demonstrated to be superior to TRT for improving BMD; KS patients are more prone to 25-OH vitamin D fluctuations than normal men. 99 Practically, biannual assessments of BMD and 25-OH vitamin D levels to evaluate the risk of osteoporosis are recommended. 80 
| KS and immune diseases
The association between KS and immune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), idiopathic juvenile arthritis, psoriatic arthritis, polymyositis/dermatomyositis, systemic sclerosis, and mixed connective tissue disease, has long been described 101, 102 ; however, there has been no systematic evi- 
| CON CLUS ION
The incidence of KS syndrome is 1:600, and the majority of patients in Japan are diagnosed upon a male infertility evaluation by medical providers, especially gynecologists and urologists. Finding sperm via micro-TESE is only one consideration for men with KS among a number of comorbidities that are found during adulthood, especially after infertility treatment. In other words, patients need lifelong care and often need a multidisciplinary team that includes general practitioners, psychologists, speech therapists, and endocrinologists in addition to urologists and gynecologists. Additionally, infertility specialists should understand the pathophysiology and previous histories of KS patients before they visit the IVF clinic, and discussions with general practitioners and pediatricians are sometimes needed to properly treat these patients. Again, KS should be managed from the infantile and pediatric periods to the geriatric period. 
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